NEW YORK – A group of 27 partners from nine European countries said on Wednesday that they have formed an alliance focused on advancing cell therapy research and access throughout the European Union.
The new alliance, dubbed T2EVOLVE, will receive funding from the EU's Innovative Medicines Initiative.